Sandoz Group reported higher sales for the second quarter, driven by a strong performance in its biosimilar segment and a return to growth in generics.
Source link
Sandoz Shares Climb After Biosimilar Sales Drive Growth
Date:
More like thisRelated
Vance appears to soften U.S. demands on Iranian nuclear enrichment
Vance says Iran must do "something meaningful on enrichment...
WATCH LIVE: President Trump is making an announcement from Oval Office
President Donald Trump will make an announcement from the...
The Netflix ‘Heartland’ Soundtrack Is Big on Country: Track List
Starring Chastain, Nettles, and Faith, in her first acting...